StonvexLoading…
StonvexStonvexStonvexCore line items from NTCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-03-31 | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $859.48M | $822.68M | $829.46M | $914.53M |
Operating Income | $109.83M | $-367.60M | $-149.83M | $77.66M |
Net Income | $95.53M | $-366.92M | $-147.73M | $59.65M |
EPS (Diluted) | $1.30 | $-5.12 | $-2.07 | $0.82 |
Total Assets | $2.35B | $2.19B | $2.60B | $2.82B |
Total Liabilities | $705.26M | $626.18M | $703.24M | $790.91M |
Cash & Equivalents | $586.50M | $457.42M | $389.67M | $386.79M |
Free Cash Flow OCF − CapEx | $285.43M | $212.26M | $52.45M | $146.17M |
Shares Outstanding | 72.06M | 71.46M | 71.40M | 71.25M |